Executive leader brings industrial biotech expertise from Corbion, LS9 and Genencor

Tjerk de Ruiter

MycoWorks today announced the appointment of independent Board Director Tjerk de Ruiter, who joins MycoWorks Board Directors Anders Spohr (Novo Holdings), Kiersten Stead (DCVC Bio), and MycoWorks CEO Matt Scullin. De Ruiter brings over 35 years’ experience in the governance and scaling of innovative, private and public biotechnology businesses with a focus on enzyme and fermentation technologies, specialty chemicals and synthetic biology.

“The advanced work that the MycoWorks team is leading through the combination of biotechnology, materials and applied science, and craftsmanship has created a unique opportunity for the company to provide new material solutions that brands and consumers are demanding. I am eager to collaborate with the team as we continue to scale the business and focus our growth of the Fine Mycelium technology,” said de Ruiter.

Read the full press release here.